Hidradenitis suppurativa trials in Canada
11 of 14 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleAn Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Where
- Edmonton, London, Montreal, Québec
- Age
- 18 years to 100 years
- People
- 710 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07665437 · EU 2025-523259-72-00 - Phase 2Taking peopleA Study to Investigate Efficacy and Safety of Duvakitug in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- Where
- Peterborough, Richmond Hill
- Age
- 18 years and over
- People
- 156 worldwide
- Run by
- Sanofi
See details and how to joinNCT07812116 - Phase 3Taking peopleRollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Where
- Barrie, Calgary, Cobourg, Edmonton, London, Markham, Mississauga, Peterborough, Québec, Richmond Hill, Saskatoon, Sherwood Park, St. John's, Toronto, Vancouver, Verdun, Waterloo, Winnipeg
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06855498 · EU 2024-520107-12-00 - Phase 2Taking peopleORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Where
- Barrie, London, Peterborough, Surrey, Waterloo
- Age
- 18 years to 79 years
- People
- 200 worldwide
- Run by
- Oruka Therapeutics, Inc.
See details and how to joinNCT07783542 - Phase 2Taking peopleA Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)
- Where
- Barrie, Edmonton, Markham, Québec, Richmond Hill, Saskatoon, Surrey, Winnipeg
- Age
- 18 years to 75 years
- People
- 150 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07766005 - Phase 2Taking peopleA Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- Where
- Mississauga, Montreal, Regina, Richmond Hill, Saskatoon, Sherbrooke, Toronto, Winnipeg
- Age
- 18 years and over
- People
- 144 worldwide
- Run by
- Sanofi
See details and how to joinNCT07225569 · EU 2025-522695-83-00 - Phase 2Taking peopleBrivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
- Where
- Edmonton, Hamilton, Kelowna, Québec, Sherwood Park, Toronto
- Age
- 18 years and over
- People
- 208 worldwide
- Run by
- Sanofi
See details and how to joinNCT07170917 · EU 2025-522333-61-00 - Phase 2Taking peoplePharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Where
- Mississauga, Richmond Hill, St. John's, Toronto
- Age
- 12 years to 17 years
- People
- 40 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07213973 - Phase 1Taking peopleA Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Where
- Calgary, Vancouver
- Age
- 18 years and over
- People
- 20 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT06888193 · EU 2024-518689-29-00 - Phase 2Taking peopleA Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
- Where
- Montreal, Toronto
- Age
- 18 years to 70 years
- People
- 150 worldwide
- Run by
- Navigator Medicines, Inc.
See details and how to joinNCT07384975 · EU 2025-523557-33-00 - Phase 3Enrolling by invitationA Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa
- Where
- Barrie, Calgary, Edmonton, Fredericton, Guelph, London, Markham, Montreal, Newmarket, Peterborough, Québec, Saskatoon, Sherwood Park, Toronto, Winnipeg
- Age
- 12 years and over
- People
- 835 worldwide
- Run by
- MoonLake Immunotherapeutics AG
See details and how to joinNCT07007637